Summary
We have established and characterized a series of variant cell lines in which to identify the critical factors associated with E2-induced malignant progression, and the acquisition to tamoxifen resistance in human breast cancer. Sublines of the hormone-dependent MCF-7 cell line (MCF7/MIII and MCF7/LCC1) form stable, invasive, estrogen independent tumors in the mammary fat pads of ovariectomized athymic nude mice. These cells retain expression of both estrogen (ER) and progesterone receptors (PGR), but retain sensitivity to each of the major structural classes of antiestrogens. The tamoxifen-resistant MCF7/LCC2 cells retain sensitivity to the inhibitory effects of the steroidal antiestrogen ICI 182780. By comparing the parental hormone-dependent and variant hormone-independent cells, we have demonstrated an altered expression of some estrogen regulated genes (PGR, pS2, cathepsin D) in the hormone-independent variants. Other genes remain normally estrogen regulated (ER, laminin receptor, EGF-receptor). These data strongly implicate the altered regulation of a specific subset or network of estrogen regulated genes in the malignant progression of human breast cancer. Some of the primary response genes in this network may exhibit dose-response and induction kinetics similar to pS2, which is constitutively upregulated in the MCF7/MIII, MCF7/LCC1 and MCF7/LCC2 cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Clarke R, Dickson RB, Lippman ME: Hormonal aspects of breast cancer: growth factors, drugs and stromal interactions. Crit Rev Oncol Hematol 12: 1–23, 1992
Henderson BE, Ross R, Bernstein L: Estrogens as a cause of human cancer. Cancer Res 48: 246–253, 1988
Clarke R, Dickson RB, Brünner N: The process of malignant progression in human breast cancer. Ann Oncol 1: 401–407, 1990
Tannock IF: Principles of cell proliferation: cell kinetics. In: Cancer: Principles and Practice of Oncology. De Vita VT, Hellman S, Rosenberg SA (eds). JB Lippincott, Philadelphia, 1989, pp 3–13
Harris JR, Henderson IC: Natural history and staging of breast cancer. In: Breast Diseases Harris JR, Hellman S, Henderson IC, Kinne DW (eds). JB Lippincott, Philadelphia, 1987
Atkinson EN, Brown BW, Montague ED: Tumor volume, nodal status and metastasis in breast cancer in women. J Natl Cancer Inst 76: 171–178, 1986
Clarke R, Brünner N, Katzenellenbogen BS, Thompson EW, Norman MJ, Koppi C, Paik S, Lippman ME, Dickson RB: Progression from hormone dependent to hormone independent growth in MCF-7 human breast cancer cells. Proc Natl Acad Sci USA 86: 3649–3653, 1989
Nowell PC: The clonal evolution of tumor cell populations. Science 194: 23–28, 1976
Isaacs JT: Clonal heterogeneity in relation to response. In: Endocrine Management of Cancer. Stoll BA (ed). Karger, Basel, 1988, pp 125–140
Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H: Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res 53: 4071–4074, 1993
Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H: Clonal analysis of human breast cancer by means of the polymerase chain reaction. Cancer Res 52: 1–4, 1992
Mashal RD, Lester SC, Sklar J: Clonal analysis by study of X chromosome inactivation in formalin-fixed paraffin-embedded tissue. Cancer Res 53: 4676–4679, 1993
Leonessa F, Boulay V, Wright A, Thompson EW, Brünner N, Clarke R: The biology of breast tumor progression: acquisition of hormone-independence and resistance to cytotoxic drugs. Acta Oncol 31: 115–123, 1991
Balakrishnan A, Yang J, Beattie CW, Gupta TKD, Nandi S: Estrogen receptor in dissociated and cultured human breast fibroadenoma epithelial cells. Br J Cancer 34: 233–242, 1987
Petersen OW, Hoyer PE, van Deurs B: Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 47: 5748–5751, 1987
Jacquemier JD, Hassoun J, Torrente M, Martin P: Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages - immunohistochemical study of 107 cases. Breast Cancer Res Treat 15: 109–117, 1990
Thompson EW, Brünner N, Torri J, Johnson MD, Boulay V, Wright A, Lippman ME, Steeg PS, Clarke R: The invasive and metastatic properties of hormone-independent and hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis 11: 15–26, 1993
Seibert K, Shafie SM, Triche TJ, Whang-Peng JJ, O'Brien SJ, Toney JH, Huff KK, Lippman ME: Clonal variation of MCF-7 breast cancer cellsin vitro and in athymic nude mice. Cancer Res 43: 2223–2239, 1983
Levy JA, White AC, McGrath CM: Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouse. Br J Cancer 45: 375–383, 1982
Russo J, McGrath C, Russo IH, Rich MA: Tumoral growth of human breast cancer cell line (MCF-7) in athymic mice. Vol. 1. In: Nieburg HE (ed). Marcel Dekker, New York, 1977, pp 617–626
Clarke R, Brünner N, Katz D, Glanz P, Dickson RB, Lippman ME, Kern F: The effects of a constitutive production of TGF-α on the growth of MCF-7 human breast cancer cellsin vitro andin vivo. Mol Endocrinol 3: 372–380, 1989
Vickers PJ, Dickson RB, Shoemaker R, Cowan KH: A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone independent tumor growth. Mol Endocrinol 2: 886–892, 1988
Clarke R, Morwood J, van den Berg HW, Nelson J, Murphy RF: The effect of cytotoxic drugs on estrogen receptor expression and response to tamoxifen in MCF-7 cells. Cancer Res 46: 6116–6119, 1986
Leonessa F, Jacobsin M, Boyle B, Lippman J, McGarvey M, Clarke R: The effect of tamoxifen on the multidrug resistant phenotype in human breast cancer cells: isobologram, drug accumulation and gp-170 binding studies. Cancer Res 54: 441–447, 1994
Goldenberg GJ, Froese EK: Antagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cellsin vitro. Biochem Pharmacol 34: 763–770, 1985
Soule HD, Vasquez J, Long A, Albert S, Brennan M: Human cell line from a pleural effusion derived from a human breast carcinoma. J Natl Cancer Inst 51: 1409–1416, 1973
Brünner N, Svenstrup B, Spang-Thompsen M, Bennet P, Nielsen A, Nielsen JJ: Serum steroid levels in intact and endocrine ablated Balb/c nude mice and their intact litter mates. J Steroid Biochem 25: 429–432, 1986
Meyvisch C: Influence of implantation site on formation of metastases. Cancer Metastasis Rev 2: 295–306, 1983
Volpe JPG, Milas L: Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases. Clin Exp Metastasis 8: 381–389, 1990
Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ: Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48: 6863–6871, 1988
Kozlowski JM, Fidler IJ, Campbell D, Xu Z-L, Kaighn ME, Hart IR: Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44: 3522–3529, 1984
Clarke R, Lippman ME, Dickson RB, Spang-Thompsen M, Brünner N:In vivo/in vitro selection of hormone independent cells from the hormone dependent MCF-7 human breast cancer cell line. In: Immune-Deficient Animal in Experimental Medicine. Wu B, Zheng J (eds). Karger, Basel, 1989, pp 190–195
Brünner N, Boulay V, Fojo A, Freter C, Lippman ME, Clarke R: Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res 53: 283–290, 1993
Clarke R, Brünner N, Thompson EW, Glanz P, Katz D, Dickson RB, Lippman ME: The inter-relationships between ovarian-independent growth, antiestrogen resistance and invasiveness in the malignant progression of human breast cancer. J Endocrinol 122: 331–340, 1989
Nawata H, Chong MT, Bronzert D, Lippman ME: Estradiolindependent growth of a subline of MCF-7 human breast cancer cells in culture. J Biol Chem 256: 6895–6902, 1981
Darbre P, Yates J, Curtis S, King RJB: Effect of estradiol on human breast cancer cells in culture. Cancer Res 43: 349–354, 1983
Bindal RD, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA: Lipophylic imputities, not phenolsulfonphthalein, account for the estrogenic properties in commercial preparations of phenol red. J Steroid Biochem 31: 287–293, 1988
Clarke R, Lippman ME: Antiestrogens resistance: mechanisms and reversal. Chapter 21. In: Drug Resistance in Oncology. Teicher BA (ed). Marcel Dekker, Inc, New York, 1992, pp 501–536
Yano T, Korkut E, Pinski J, Szepeshazi K, Milovanovic S, Groot K, Clarke R, Comaru-Schally AM, Schally AV: Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LHRH. Breast Cancer Res Treat 21: 35–45, 1992
Brodie AMH, Santen RJ: Aromatase in breast cancer and the role of aminogluthemide and other aromatase inhibitors. Crit Rev Oncol Hematol 5: 361–396, 1985
Pasqualini JR, Nguyen B-L: Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs independent human breast cancer cell lines. Breast Cancer Res Treat 18: 93–98, 1991
Brünner N, Frandsen TL, Holst-Hansen C, Bei M, Thompson EW, Wakeling AE, Lippman ME, Clarke R: MCF7/LCC2: A 4-hydroxytamoxifen resistant human breast cancer variant which retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Res 53: 3229–3232, 1993
Coopman P, Garcia M, Brünner N, Derocq D, Clarke R, Rochefort H: Antiproliferative and antiestrogenic effects of ICI 164,384 in 4-OH-Tamoxifen-resistant human breast cancer cells. Int J Cancer 56: 295–300, 1994
Nicholson RI, Gee JMW, Anderson E, Dowsett M, DeFriend D, Howell A, Robertson JFR, Blamey RW, Baum M, Saunders C, Walton P, Wakeling AE: Phase I study of a new pure antiestrogen ICI 182,780 in women with primary breast cancer: immunohistochemical analysis. Breast Cancer Res Treat 27: 135, 1993
Liotta LA: Tumor invasion and metastasis-role of the extracellular matrix. Cancer Res 46: 1–7, 1986
Fidler IJ: Critical factors in the biology of human cancer metastasis. Cancer Res 50: 6130–6138, 1990
Thompson EW, Reich R, Shima TB, Albini A, Graf J, Martin GR, Dickson RB, Lippman ME: Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res 48: 6764–6768, 1988
Castronovo V, Taraboletti G, Liotta LA, Sobel ME: Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. J Natl Cancer Inst 81: 781–788, 1989
Johnson MD, Torri JA, Lippman ME, Dickson RB: The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 53: 873–877, 1993
Ozzello L, Sordat M: Behavior of tumors produced by transplantation of human mammary cell lines in athymic nude mice. Eur J Cancer 16: 533–559, 1980
Shafie SM, Liotta LA: Formation of metastasis by human carcinoma cells (MCF-7) in nude mice. Cancer Lett 11: 81–87, 1980
Thompson EW, Paik S, Brünner N, Sommers C, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, Martin GR, Dickson RB: Association of increased basement membrane-invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534–544, 1992
Freter CE, Lippman ME, Cheville A, Zinn S, Gelmann EP: Alterations in phosphoinositide metabolism associated with 17β-estradiol and growth factor treatment of MCF-7 breast cancer cells. Mol Endocrinol 2: 159–166, 1988
Brown AMC, Jeltsch J-M, Roberts M, Chambon P: Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81: 6344–6348, 1984
Clarke R, Thompson EW, Leonessa F, Lippman J, McGarvey M, Brünner N: Hormone resistance, invasiveness and metastatic potential in human breast cancer. Breast Cancer Res Treat 24: 227–239, 1993
Haagensen CD: In: Diseases of the Breast. Vol. 3. WB Saunders Company, Philadelphia, 1986, pp 903–932
Henderson IC, Shapiro CL: Adjuvant chemotherapy: an overview. Chapter 21. In: Medical Management of Breast Cancer. Powles T, Smith IE (eds). Dunitz, London, 1991, pp 197–215
Skaar T, Prasad S, Sharareh S, Brünner N, Lippman ME, Clarke R: 2-Dimensional gel electrophoretic analyses of an acquired hormone-independent phenotype in human breast cancer. Breast Cancer Res Treat 27: 184, 1993
Cato AC, Konig H, Ponta H, Herrlich P: Steroids and growth promoting factors in the regulation of expression of genes and gene networks. J Steroid Biochem Mol Biol 1992, Sep 43: 63–68, 1993
Murray A, Hunt T: In: The Cell Cycle. WH Freeman & Co., New York, 1993, pp 42–65
Kyprianou N, English HF, Davidson NE, Isaacs JT: Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162–166, 1991
Clarke R, Dickson RB: Animal models of tumor onset, growth and metastasis. In: Molecular Biology of Cancer. Bertino JR (ed). Academic Press, Inc., San Diego, 1994, in press
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clarke, R., Skaar, T., Baumann, K. et al. Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res Tr 31, 237–248 (1994). https://doi.org/10.1007/BF00666157
Issue Date:
DOI: https://doi.org/10.1007/BF00666157